1	Tumor	tumor	_	_	_	_	_	_	_
2	necrosis	necrosis	_	_	_	_	_	_	_
3	factor	factor	_	_	_	_	_	_	_
4	receptor	receptor	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	signal	signal	_	_	_	_	_	_	_
8	transduction	transduction	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	HIV-1-infected	hiv-1-infected	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	OBJECTIVE	objective	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	To	to	_	_	_	_	_	_	_
4	examine	examine	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	inter-relationship	inter-relationship	_	_	_	_	_	_	_
7	between	between	_	_	_	_	_	_	_
8	HIV-1	HIV-1	_	_	_	_	_	_	_
9	infection	infection	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	surface	surface	_	_	_	_	_	_	_
14	receptors	receptor	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	tumor	tumor	_	_	_	_	_	_	_
17	necrosis	necrosis	_	_	_	_	_	_	_
18	factor	factor	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	TNF)-alpha	TNF)-alpha	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	an	an	_	_	_	_	_	_	_
23	immunoregulatory	immunoregulatory	_	_	_	_	_	_	_
24	cytokine	cytokine	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	can	can	_	_	_	_	_	_	_
27	enhance	enhance	_	_	_	_	_	_	_
28	HIV-1	HIV-1	_	_	_	_	_	_	_
29	replication	replication	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	DESIGN	design	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Infected	infected	_	_	_	_	_	_	_
4	promyelocytic	promyelocytic	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	promonocytic	promonocytic	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	examined	examine	_	_	_	_	_	_	_
10	because	because	_	_	_	_	_	_	_
11	they	they	_	_	_	_	_	_	_
12	normally	normally	_	_	_	_	_	_	_
13	express	express	_	_	_	_	_	_	_
14	both	both	_	_	_	_	_	_	_
15	types	type	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	TNF	TNF	_	_	_	_	_	_	_
18	receptors	receptor	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	TNF	TNF	_	_	_	_	_	_	_
4	receptor	receptor	_	_	_	_	_	_	_
5	surface	surface	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	determined	determine	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	specific	specific	_	_	_	_	_	_	_
11	monoclonal	monoclonal	_	_	_	_	_	_	_
12	antibody	antibody	_	_	_	_	_	_	_
13	recognition	recognition	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	flow	flow	_	_	_	_	_	_	_
16	cytometry	cytometry	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	signal	signal	_	_	_	_	_	_	_
20	transduction	transduction	_	_	_	_	_	_	_
21	was	be	_	_	_	_	_	_	_
22	detected	detect	_	_	_	_	_	_	_
23	by	by	_	_	_	_	_	_	_
24	gel	gel	_	_	_	_	_	_	_
25	shift	shift	_	_	_	_	_	_	_
26	analysis	analysis	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	HIV-1	HIV-1	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	quantitated	quantitate	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	reverse	reverse	_	_	_	_	_	_	_
9	transcriptase	transcriptase	_	_	_	_	_	_	_
10	assay	assay	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	In	in	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	OM-10.1	om-10.1	_	_	_	_	_	_	_
6	promyelocytic	promyelocytic	_	_	_	_	_	_	_
7	model	model	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	chronic	chronic	_	_	_	_	_	_	_
10	infection	infection	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	TNF-alpha-induced	tnf-alpha-induced	_	_	_	_	_	_	_
13	HIV-1	HIV-1	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	also	also	_	_	_	_	_	_	_
16	resulted	result	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	substantial	substantial	_	_	_	_	_	_	_
20	increase	increase	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	75	75	_	_	_	_	_	_	_
23	kd	kd	_	_	_	_	_	_	_
24	TNF	TNF	_	_	_	_	_	_	_
25	receptor	receptor	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	TR75	TR75	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	expression	expression	_	_	_	_	_	_	_
30	although	although	_	_	_	_	_	_	_
31	55	55	_	_	_	_	_	_	_
32	kD	kd	_	_	_	_	_	_	_
33	TNF	TNF	_	_	_	_	_	_	_
34	receptor	receptor	_	_	_	_	_	_	_
35	(	(	_	_	_	_	_	_	_
36	TR55	TR55	_	_	_	_	_	_	_
37	)	)	_	_	_	_	_	_	_
38	levels	level	_	_	_	_	_	_	_
39	were	be	_	_	_	_	_	_	_
40	not	not	_	_	_	_	_	_	_
41	dramatically	dramatically	_	_	_	_	_	_	_
42	altered	alter	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	series	series	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	uninfected	uninfected	_	_	_	_	_	_	_
5	parental	parental	_	_	_	_	_	_	_
6	HL-60	hl-60	_	_	_	_	_	_	_
7	subclones	subclone	_	_	_	_	_	_	_
8	all	all	_	_	_	_	_	_	_
9	reduced	reduce	_	_	_	_	_	_	_
10	TR75	tr75	_	_	_	_	_	_	_
11	surface	surface	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	response	response	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
17	treatment	treatment	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Enhanced	enhance	_	_	_	_	_	_	_
2	TR75	tr75	_	_	_	_	_	_	_
3	expression	expression	_	_	_	_	_	_	_
4	on	on	_	_	_	_	_	_	_
5	OM-10.1	om-10.1	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	followed	follow	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	same	same	_	_	_	_	_	_	_
10	TNF-alpha-dose	tnf-alpha-dose	_	_	_	_	_	_	_
11	dependency	dependency	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	that	that	_	_	_	_	_	_	_
14	observed	observe	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	HIV-1	HIV-1	_	_	_	_	_	_	_
17	production	production	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	An	an	_	_	_	_	_	_	_
2	increase	increase	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	TR75	TR75	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	also	also	_	_	_	_	_	_	_
8	evident	evident	_	_	_	_	_	_	_
9	during	during	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	peak	peak	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	an	an	_	_	_	_	_	_	_
14	acute	acute	_	_	_	_	_	_	_
15	HIV-1	HIV-1	_	_	_	_	_	_	_
16	infection	infection	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	HL-60	HL-60	_	_	_	_	_	_	_
19	promyelocytes	promyelocyte	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	TR55	TR55	_	_	_	_	_	_	_
3	expression	expression	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	unaltered	unaltered	_	_	_	_	_	_	_
6	during	during	_	_	_	_	_	_	_
7	TNF-alpha-induced	tnf-alpha-induced	_	_	_	_	_	_	_
8	HIV	HIV	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	this	this	_	_	_	_	_	_	_
12	receptor	receptor	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	still	still	_	_	_	_	_	_	_
15	involved	involve	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	viral	viral	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	process	process	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Antibody	antibody	_	_	_	_	_	_	_
2	cross-linking	cross-linking	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	TR55	TR55	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	absence	absence	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	exogenous	exogenous	_	_	_	_	_	_	_
11	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	induced	induce	_	_	_	_	_	_	_
14	maximal	maximal	_	_	_	_	_	_	_
15	HIV-1	HIV-1	_	_	_	_	_	_	_
16	expression	expression	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	up-modulation	up-modulation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	surface	surface	_	_	_	_	_	_	_
22	TR75	tr75	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	nuclear	nuclear	_	_	_	_	_	_	_
26	NF-kappa	NF-kappa	_	_	_	_	_	_	_
27	B	B	_	_	_	_	_	_	_
28	activity	activity	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	OM-10.1	om-10.1	_	_	_	_	_	_	_
31	cultures	culture	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Surprisingly	surprisingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	case	case	_	_	_	_	_	_	_
7	even	even	_	_	_	_	_	_	_
8	when	when	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	antagonistic	antagonistic	_	_	_	_	_	_	_
11	anti-TR55	anti-tr55	_	_	_	_	_	_	_
12	antibody	antibody	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	used	use	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Anti-TR55	anti-tr55	_	_	_	_	_	_	_
2	antibody	antibody	_	_	_	_	_	_	_
3	cross-linking	cross-linking	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	chronically	chronically	_	_	_	_	_	_	_
6	infected	infected	_	_	_	_	_	_	_
7	U1	u1	_	_	_	_	_	_	_
8	promonocytic	promonocytic	_	_	_	_	_	_	_
9	cultures	culture	_	_	_	_	_	_	_
10	could	could	_	_	_	_	_	_	_
11	only	only	_	_	_	_	_	_	_
12	partially	partially	_	_	_	_	_	_	_
13	substitute	substitute	_	_	_	_	_	_	_
14	for	for	_	_	_	_	_	_	_
15	TNF-alpha-induced	tnf-alpha-induced	_	_	_	_	_	_	_
16	HIV-1	HIV-1	_	_	_	_	_	_	_
17	expression	expression	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	CONCLUSIONS	conclusions	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Our	our	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	demonstrated	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	HIV-1	HIV-1	_	_	_	_	_	_	_
8	infection	infection	_	_	_	_	_	_	_
9	can	can	_	_	_	_	_	_	_
10	selectively	selectively	_	_	_	_	_	_	_
11	influence	influence	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	surface	surface	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	TNF	TNF	_	_	_	_	_	_	_
17	receptors	receptor	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	potentially	potentially	_	_	_	_	_	_	_
20	influencing	influence	_	_	_	_	_	_	_
21	its	its	_	_	_	_	_	_	_
22	own	own	_	_	_	_	_	_	_
23	expression	expression	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	altering	alter	_	_	_	_	_	_	_
26	normal	normal	_	_	_	_	_	_	_
27	immunoregulatory	immunoregulatory	_	_	_	_	_	_	_
28	signal	signal	_	_	_	_	_	_	_
29	transduction	transduction	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

